These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 29566639)
1. Integrative analysis of gene expression and DNA methylation using unsupervised feature extraction for detecting candidate cancer biomarkers. Moon M; Nakai K J Bioinform Comput Biol; 2018 Apr; 16(2):1850006. PubMed ID: 29566639 [TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma. Singh NP; Vinod PK Mol Genet Genomics; 2020 May; 295(3):807-824. PubMed ID: 32185457 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma. Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033 [TBL] [Abstract][Full Text] [Related]
4. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma. Chen G; Wang Y; Wang L; Xu W Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655 [TBL] [Abstract][Full Text] [Related]
5. Identification of genes and pathways involved in kidney renal clear cell carcinoma. Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354 [TBL] [Abstract][Full Text] [Related]
6. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data. Guan L; Tan J; Li H; Jin X Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611 [TBL] [Abstract][Full Text] [Related]
7. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data. El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801 [TBL] [Abstract][Full Text] [Related]
8. Integrative pathway-based survival prediction utilizing the interaction between gene expression and DNA methylation in breast cancer. Kim SY; Kim TR; Jeong HH; Sohn KA BMC Med Genomics; 2018 Sep; 11(Suppl 3):68. PubMed ID: 30255812 [TBL] [Abstract][Full Text] [Related]
9. A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data. Mallik S; Seth S; Bhadra T; Zhao Z Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806782 [TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China. Wang J; Duan Y; Meng QH; Gong R; Guo C; Zhao Y; Zhang Y PLoS One; 2018; 13(10):e0203155. PubMed ID: 30286088 [TBL] [Abstract][Full Text] [Related]
11. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer. Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858 [TBL] [Abstract][Full Text] [Related]
12. Identifying Epigenetic Biomarkers using Maximal Relevance and Minimal Redundancy Based Feature Selection for Multi-Omics Data. Mallik S; Bhadra T; Maulik U IEEE Trans Nanobioscience; 2017 Jan; 16(1):3-10. PubMed ID: 28092570 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cross-omics screening for kidney clear cell renal cancer survival. Dimitrieva S; Schlapbach R; Rehrauer H Biol Direct; 2016 Dec; 11(1):68. PubMed ID: 27993167 [TBL] [Abstract][Full Text] [Related]
14. Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer. Bhalla S; Chaudhary K; Kumar R; Sehgal M; Kaur H; Sharma S; Raghava GP Sci Rep; 2017 Mar; 7():44997. PubMed ID: 28349958 [TBL] [Abstract][Full Text] [Related]
15. An integrated analysis of cancer genes in clear cell renal cell carcinoma. Li J; Guo L; Ai Z Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251 [TBL] [Abstract][Full Text] [Related]
16. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma. Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920 [TBL] [Abstract][Full Text] [Related]
18. Type 1 and 2 papillary renal cancers are genetically distinct. Balakrishnan VS Lancet Oncol; 2015 Dec; 16(16):e594. PubMed ID: 26596671 [No Abstract] [Full Text] [Related]
19. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation. Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734 [TBL] [Abstract][Full Text] [Related]
20. Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data. Huo X; Sun H; Cao D; Yang J; Peng P; Yu M; Shen K Sci Rep; 2019 Jul; 9(1):9924. PubMed ID: 31289358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]